$1.58 Billion is the total value of Bellevue Group AG's 138 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABC | AMERISOURCEBERGEN CORP | $22,027,000 | +8.2% | 238,853 | 0.0% | 1.40% | -19.5% | |
| WBA | WALGREENS BOOTS ALLIANCE INC | $16,477,000 | +21.5% | 226,018 | 0.0% | 1.04% | -9.6% | |
| HOLX | HOLOGIC INC | $14,830,000 | +3.1% | 361,894 | 0.0% | 0.94% | -23.2% | |
| HSIC | SCHEIN HENRY INC | $4,368,000 | +17.1% | 51,368 | 0.0% | 0.28% | -12.9% | |
| ESRX | EXPRESS SCRIPTS HLDG CO | $4,228,000 | +23.1% | 44,500 | 0.0% | 0.27% | -8.5% | |
| JNJ | JOHNSON & JOHNSON | $2,763,000 | +13.8% | 20,000 | 0.0% | 0.18% | -15.5% | |
| PODD | INSULET CORP | $1,907,000 | +23.6% | 18,000 | 0.0% | 0.12% | -8.3% | |
| ANGO | ANGIODYNAMICS INC | $1,646,000 | -2.3% | 75,700 | 0.0% | 0.10% | -27.8% | |
| AET | AETNA INC NEW | $1,440,000 | +10.5% | 7,100 | 0.0% | 0.09% | -18.0% | |
| PFE | PFIZER INC | $1,287,000 | +21.5% | 29,200 | 0.0% | 0.08% | -8.9% | |
| MRK | MERCK & CO INC | $887,000 | +16.9% | 12,500 | 0.0% | 0.06% | -13.8% | |
| VAR | VARIAN MED SYS INC | $705,000 | -1.5% | 6,300 | 0.0% | 0.04% | -26.2% | |
| CVS | CVS HEALTH CORP | $630,000 | +22.3% | 8,000 | 0.0% | 0.04% | -9.1% | |
| HCSG | HEALTHCARE SVCS GRP INC | $609,000 | -6.0% | 15,000 | 0.0% | 0.04% | -29.1% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bellevue Asset Management AG #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.